Ellington Management Group Has Cut By $670,800 Its Mercadolibre (MELI) Holding; Citius Pharmaceuticals (CTXR) Shorts Raised By 347.06%

August 27, 2017 - By Migdalia James

Ellington Management Group Llc decreased Mercadolibre Inc (MELI) stake by 48.31% reported in 2016Q4 SEC filing. Ellington Management Group Llc sold 4,300 shares as Mercadolibre Inc (MELI)’s stock rose 37.36%. The Ellington Management Group Llc holds 4,600 shares with $718,000 value, down from 8,900 last quarter. Mercadolibre Inc now has $10.88 billion valuation. The stock increased 1.15% or $2.79 on August 25, reaching $246.41. About 667,971 shares traded. Mercadolibre Inc (NASDAQ:MELI) has risen 106.82% since August 27, 2016 and is uptrending. It has outperformed by 90.12% the S&P500.

Citius Pharmaceuticals Incorporated (NASDAQ:CTXR) had an increase of 347.06% in short interest. CTXR’s SI was 7,600 shares in August as released by FINRA. Its up 347.06% from 1,700 shares previously. With 12,000 avg volume, 1 days are for Citius Pharmaceuticals Incorporated (NASDAQ:CTXR)’s short sellers to cover CTXR’s short positions. The stock increased 4.81% or $0.13 on August 25, reaching $2.83. About 28,435 shares traded or 10.17% up from the average. Citius Pharmaceuticals Inc (NASDAQ:CTXR) has 0.00% since August 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company has market cap of $23.36 million. The Firm is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. It currently has negative earnings. The Company’s product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream.

Since March 9, 2017, it had 0 buys, and 1 sale for $422,000 activity. Tolda Stelleo sold $422,000 worth of Mercadolibre Inc (NASDAQ:MELI) on Thursday, March 9.

Among 13 analysts covering MercadoLibre (NASDAQ:MELI), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. MercadoLibre had 27 analyst reports since August 6, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Hold” rating in Friday, August 4 report. The stock has “Sell” rating by Citigroup on Monday, September 28. JP Morgan maintained the shares of MELI in report on Monday, May 16 with “Neutral” rating. Susquehanna downgraded the shares of MELI in report on Monday, December 5 to “Neutral” rating. The stock of Mercadolibre Inc (NASDAQ:MELI) has “Neutral” rating given on Monday, March 14 by JP Morgan. The stock of Mercadolibre Inc (NASDAQ:MELI) earned “Overweight” rating by Barclays Capital on Wednesday, July 19. J.P. Morgan maintained it with “Hold” rating and $27000 target in Wednesday, August 9 report. Citigroup upgraded the shares of MELI in report on Monday, June 19 to “Buy” rating. Cowen & Co initiated it with “Market Perform” rating and $120 target in Monday, April 25 report. Stifel Nicolaus maintained Mercadolibre Inc (NASDAQ:MELI) rating on Thursday, October 6. Stifel Nicolaus has “Hold” rating and $180 target.